T 0495/09 (Treatment of autoimmune diseases/GENENTECH) of 01.06.2010
- European Case Law Identifier
- ECLI:EP:BA:2010:T049509.20100601
- Date of decision
- 1 June 2010
- Case number
- T 0495/09
- Online on
- 25 May 2011
- Petition for review of
- -
- Application number
- 00928991.9
- IPC class
- A61K 39/395
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
- Applicant name
- Genentech, Inc., et al
- Opponent name
- 01 Trubion Pharmaceuticals, Inc.
02 MEDIMMUNE, INC.
03 Elend, Almut Susanne
04 CENTOCOR, INC.
05 GLAXO GROUP LIMITED
06 Merck Serono SA
07 Genmab A/S
08 Wyeth - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Admissibility auxiliary request - yes
Added matter - no
Remittal - yes - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division for further prosecution on the basis of the auxiliary request filed on 30 April 2010.